“Domestic biotech must have data competitiveness to attract US investment”
Bio USA 2023 Korea Pavilion booth. / Photo = Reporter Nam Dae-yeol While domestic biopharmaceutical companies have been moving to Boston, USA for global commercialization over the past few years, industry insiders advise that they should challenge entering the US market through thorough preparation. A total of 20 companies, including △Yuhan USA △Dong-A ST △Huons […]
